The Antibody Society has partnered with numerous conference organizers, including KNect365, Cambridge Healthtech Institute, Hanson Wade and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
The 4th Adaptive Immune Response Repertoire Community Meeting will be held May 11-15, 2019 at the University of Genoa Scuola Politecnica, Italy. The theme of this meeting, “Bridging the Gaps” addresses technological gaps between the amounts of accumulated data and our ability to process them, and the need for more involvement of stakeholder communities (industry, clinicians, patient communities) for uptake of the standards developed by the AIRR Community.
We have confirmed two outstanding Keynote speakers – Dr. Sai Reddy from ETH Zurich and Dr. Antonio Lanzavecchia from IRB Bellinzona. Two planned panel discussions will include representatives from other institutions and companies that work with AIRR-seq data. In addition, two “challenge” sessions are planned to address the above-mentioned gaps. Two pre-meeting workshops will be available to teach the basics of immunology, and of AIRR-seq data analysis for beginners. Two poster sessions and two tool and software demos sessions are also planned.
More information and the draft agenda can be found here.
Registration for this meeting is now open – click here to register!
Antibodies & Complement
May 20-25, 2019, Girona, Spain
This 2nd conference on Antibodies & Complement will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts. Some of the critical topics to be covered include:
- antibody & complement (novel) functions
- human antibody repertoires
- complement structure and subcellular localization
- novel technologies
- complement and antibody therapies
After the success of the first edition, this second conference on Antibodies & Complement should again be a forum for leaders in the field and new investigators coming from academia, industry and research institutes to discuss where the field is going and what challenges lie ahead.
Antibody Engineering & Therapeutics Europe
June 11-13, 2019
Postillion Hotel Amsterdam, the Netherlands
Join us for The Antibody Society’s 2nd annual Antibody Engineering & Therapeutics Europe meeting, where you will connect with industry and academic scientists and executives from Europe and around the world focused on antibody and protein therapeutic discovery and development.
Keynote speakers Jane Osbourn, Ph.D., (Vice President R&D and Site Leader of Medimmune) will discuss antibody therapeutic developments, pipeline and progress at Medimmune and Hans Clevers, M.D., Ph.D., (Group Leader, Hubrecht Institute for Developmental Biology and Stem Cell Research and Professor of Molecular Genetics, University Medical Center Utrecht and Utrecht University) will discuss Lgr5 stem cell-based organoids and their applications in cancer research. In addition, the meeting features sessions on Turning Antibody Leads into Drugs, Recent Advances in Immuno-Oncology Approaches, Bioinformatics and Repertoires in Antibody Discovery and Development, Antibody Therapeutics for Autoimmune and Neurodegenerative Diseases, Clinical Developments in Antibody Therapeutics, and New Antibody Formats and Effector Functions.
Society members save 15% on the registration fee when using the code Antibody15!
NEW FOR 2019!
Antibody Engineering & Therapeutics Europe Student/Postdoc Poster Competition
To recognize the research activities of promising student/postdoc attendees of the Antibody Engineering & Therapeutics conference, The Antibody Society is sponsoring a student/postdoc poster competition. Two student/postdoc winners will be selected to receive:
1) Complimentary registration to attend the conference and pre-conference sessions;
2) Support for travel expenses (up to $400 for domestic or $800 for international flights, 2 nights at a hotel, ground transportation).
In order to be considered for this poster competition, you must be a student or postdoc member of The Antibody Society. If you are not already a member, you may register here for a free student or postdoc membership. KNect365 is managing the poster submission process. Please use the form located here to submit your poster, and be sure to check the box on the poster submission form indicating that you want your abstract to be considered for the poster competition.
Deadline for submission: April 24, 2019
Winners will be notified by May 1, 2019
The Antibody Society’s Symposium at the Federation of Clinical Immunology Societies (FOCIS) annual meeting
June 18, 2019
Boston Marriott Copley Place, Boston, MA
“Developing Therapeutic Antibodies for Successful Entry into the Clinic”
Although many antibody-engineering labs are focused on translational work, most antibody-based therapeutics developed in academia, and many developed by small companies, either do not make it into clinical study or do not proceed past Phase 1. Few are ultimately licensed by large pharmaceutical firms because many antibodies developed in academic labs are not associated with sufficiently robust characteristics to allow successful commercial development.
In addition, academic labs and small biotech often encounter difficulty in securing funding for the development of clinical-grade material and subsequent clinical trials. Taking interesting laboratory discoveries to the next step is further hindered by a lack of knowledge about what venture capital (VC)/biotech/pharma companies are interested in, who to talk to, and how to make a deal. What makes a new antibody-based therapeutic sufficiently novel to attract interest?
This symposium is designed to bring together scientists and entrepreneurs who will share their experiences with successfully tackling these and other issues that block the clinical development of many antibody-based therapeutics.
For more information and to register for the meeting, click here.
8.00-8.35am Greg Adams (Sesen Bio)
- Introduction to The Antibody Society and the purpose of this symposium
- Why does this session matter to academic/biotech scientists who want to develop clinical agents?
8.35-9.10am Yingda Xu (Adimab)
- Designing and screening for the properties that decrease the risk of failure during clinical development of an antibody
- Screening for function, stability and specificity
9.10-9.45am Wayne Marasco (MGH/Harvard)
- Screening antibodies for clinically relevant function
- Investigator-initiated Phase 1 clinical studies
9.45-10.15am Coffee break
10.15-10.50am Jim Larrick (Panorama Research Institute, Velocity Pharmaceutical Development)
- Supporting clinical research with grant funding
- Taking a preclinical lead to the clinic
10.50-11.25am Patrick Baeuerle (MPM Capital)
- Bringing a new class of antibodies to the clinic
- Building a biotech
- Selling to pharma
- View from the VC world
11.25-12.00 Abbie Celniker (3rd Rock Ventures)
- Formation and development of VC-backed companies
- What does a VC look for: 1) in a platform or 2) in a scientific team?
7th Antibody Industrial Symposium
June 24-25, Tours, France
The 7th Antibody Industrial Symposium (AIS2019) will be held on June 24-25, 2019 in Tours, France. The AIS provides an ideal congress to keep up to date with the latest innovation and progress in the exciting field of therapeutic antibodies.
We are thrilled to share with you that this year edition will focus on Harnessing the Immune System with therapeutic antibodies, a major topic chosen by the AIS Scientific Advisory Board constituted by Pierre Fabre, Servier, IRCM, MabDesign, Sanofi, OSE Immunotherapeutics, LFB, CEPR, IGMM, LabEx MabImprove, and Tours University. Indeed, immune responses can be modulated with mAbs and may be harnessed to enhance antibody functions. The AIS2019 will cover the multifaceted mechanisms underlying antibody-mediated immune responses.
Join more than 300 experts expected for this new edition, working in the field of mAbs and related services and technologies and hear the latest advances in academia and how industry is pushing forward innovation for the development of new therapies. Register HERE.
Submit an Abstract to give a Pitch or Present a Poster: Deadline March 29, 2019
Check the guideline online HERE.
Society members save 20% on the registration fee! Contact us at email@example.com for the code.
Cell Engager Summit
June 25-27, 2019, Boston, MA
The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic.
Overcome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug.
Discover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies.
Society members save 10% on the registration fee! Contact us at firstname.lastname@example.org for the code.
September 5 – 6, 2019, University of Bonn, Germany
This symposium will bring together scientists from different disciplines who do (or would like to) develop, modify, and apply nanobodies for basic research, diagnostics, and therapy. It will thus be a forum to exchange experience and knowledge across different fields, and hear about the latest research in both the generation and application of nanobodies. Attendees will hear 18 outstanding scientists give invited lectures at the symposium, and there will be ample time for further presentations and posters from selected participants. Workshops to foster exchange of practical information are planned.
Please visit our website for further information (including the speaker list).
Please note the following details for your calendar:
Venue: University of Bonn, Venusberg campus, Biomedical Center (Building 13), Lecture Hall
Date and Time: September 5 – 6, 2019
Program: Invited and selected presentations, workshops, and poster session (evening of September 5th)
Contact: Please contact us using this email address: email@example.com
10th Annual World Bispecific
September 17-19, 2019
World Bispecific is the Only End-to-End Meeting Dedicated Solely to Enhancing the Development of Bispecific Therapeutics
In the context of unprecedented clinical progress, World Bispecific will deliver a greater breadth and depth of technical content than any other conference.
Returning for the tenth year, the reimagined agenda will devote specific tracks to the unique discovery, translational and manufacturing challenges encountered in the bispecific space, ensuring that whatever your role in the field, you will leave with tangible actions to implement into your strategy and pipeline to translate the promise of bispecific therapeutics into a reality for patients.
Download the event guide for more information.
Society members save 10% on the registration fee! Contact us at firstname.lastname@example.org for the code.
Festival of Biologics
October 15-17, 2019, Basel Switzerland
The Festival of Biologics combines four outstanding conferences, the European Antibody Congress, the World Immunotherapy Congress, the World Biosimilar Congress and the Clinical Trials World Congress under one roof.
The Festival of Biologics 2019 will address the strategic and commercial aspects of discovering, developing, and bringing new biologics to patients with high level, global speakers from big pharma, biotech, academia and industry . We will bring you three days packed full of top level science, data and case studies, workshops, roundtables and networking opportunities bringing together 350+ speakers, 100 sponsors and exhibitors and over 1500 attendees. This is not an event to be missed.
Register by May 3 to take advantage of early bird rates!
Society members save 15% on the registration fee! Contact us at email@example.com for the code.